Innovations to Improve ART Care Adherence in Tanzania

Most antiretroviral therapy (ART) regimens require more than 80-95% adherence to maximize the probability of viral suppression, the ultimate goal of treatment that has significant clinical benefits and can virtually eliminate HIV transmission. However, a significant proportion of people living with HIV infection (PLHIV) on treatment have sub-optimal adherence and overall, only 29% of PLHIV are virally suppressed. This problem is a result of multifaceted factors that need to be addressed in efforts to curb the HIV/AIDS pandemic. For years countries have implemented various strategies to address this gap with some innovations giving some promising results. A major concern globally remains to be paucity of proven and scalable innovations. Which is call for experts to continue innovating, studying and documenting best and scalable practices.

Sexual & Reproductive Health

Using a patient- centered design approach to facilitate a co designing process with end beneficiaries to address the drivers of poor adherence to ART treatment.

Discover Learning

A study led by an experienced Tanzanian researcher in partnership with University of California, Berkeley, John Hopkins University & Save the Children Tanzania.

Afya I – improving ART Care Adherence

Using a patient- centered design approach to facilitate a co designing process with end beneficiaries to address the drivers of poor adherence to ART treatment.

Afya II, Improving ART care adherence

This project tests the known fact that financial incentives and food security can motivate behavior change and improve outcomes along the HIV care continuum.